HCW Biologics regains rights to CAR-T therapy reagents from Wugen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. NVDA
3. SPCX
4. MU
5. LCO
6. KR
7. APGE
8. MSTR
9. ABBV
10. DFTX

Go back to HCW Biologics regains rights to CAR-T therapy reagents from Wugen
(NASDAQ: HCWB) Delayed: 1.02 -0.07 (6.42%)
Previous Close $1.09    52 Week High $ 
Open $1.07    52 Week Low $ 
Day High $1.10    P/E N/A 
Day Low $1.00    EPS $ 
Volume 571,682